Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.841
+0.006 (0.66%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $18.81 million as of March 9, 2026. Its market cap has increased by 18.30% in one year.
Market Cap
18.81M
Enterprise Value
12.79M
1-Year Change
18.30%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $18.81M, a decrease of -38.73%. That is a compound annual growth rate of -5.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 18.70M | 16.15% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |
| Allarity Therapeutics | 19.94M |
| VYNE Therapeutics | 19.83M |